Calcitonin effects in primate pregnancy.

Area of Science:

• Reproductive Endocrinology
• Calcium Homeostasis
• Pharmacology

Background:

• Calcitonin (CT) is a hormone known to inhibit bone resorption and lower calcium levels.
• Pregnancy involves significant physiological changes in calcium metabolism for both mother and fetus.
• The role of CT in maternal-fetal calcium dynamics during gestation remains incompletely understood.

Purpose of the Study:

• To investigate the acute effects of calcitonin (CT) on maternal and fetal calcium and inorganic phosphorus levels in late-term pregnant rhesus monkeys.
• To compare the hypocalcemic response to CT in pregnant versus non-pregnant animals.
• To determine the impact of maternal versus fetal CT administration on plasma calcium concentrations.

Main Methods:

• Intravenous administration of salmon calcitonin (CT) to either pregnant rhesus monkey mothers or their fetuses.
• Measurement of total calcium and inorganic phosphorus concentrations in maternal plasma, fetal plasma, and amniotic fluid.
• Dose-response analysis of CT effects on calcium and phosphorus levels.

Main Results:

• Maternal CT administration led to a dose-dependent decrease in maternal plasma calcium and, to a lesser extent, phosphorus.
• The hypocalcemic response in pregnant animals was more pronounced than in non-pregnant animals at equivalent doses.
• Fetal CT administration induced a triphasic response in fetal plasma calcium: an initial drop, a rebound, and a subsequent decline, all dose-related.
• Maternal hypocalcemia induced by CT was not reflected in the fetus.

Conclusions:

• Calcitonin plays a significant role in regulating calcium levels in both maternal and fetal physiology during late pregnancy.
• The pregnant state enhances the hypocalcemic sensitivity to CT in the mother.
• Fetal exposure to CT elicits a complex, dose-dependent biphasic hypocalcemic effect in the fetus, suggesting distinct fetal regulatory mechanisms.